CEO & Founder, Avanzanite Bioscience
Amsterdam, the Netherlands
Joined December 2021
- Tweets10
- Following2
- Followers8
- Likes0
Adam Andrzej Plich retweeted
“Together with my colleagues in Germany and Europe, we have a great opportunity and mission to significantly improve the lives of people with rare diseases.” businesswire.com/news/home/2…
#innovation #orphandrugs #raredisease #dRTA #nephrology #pediatricnephrology #pediatrics #kidney
2023 Knights for Rare: The Acanthamoeba Keratitis Eye Foundation youtu.be/Z3GAYgnnaDQ via @YouTube #raredisease
Adam Andrzej Plich retweeted
Today is #rarediseaseday and we are excited to share that we've partnered with #Advicenne in distal Renal Tubular Acidosis (#dRTA).
businesswire.com/news/home/2…
#raredisease #patientsfirst #orphandrugs
READ more about our partnership with SIFI in #acanthamoebakeratitis #RareDiseases #orphandrugs #innovation #patientsfirst
prnewswire.com/news-releases…
Read about Avanzanite in the latest issue of @Biotech_finance #orphandrugs #raredisease #patientaccess #innovation
Avanzanite Bioscience looks to commercialize innovative medicines for rare diseases in Europe labiotech.eu/trends-news/ava… via @Labiotech_eu #rarediseases #orphandrugs #innovation
BRIEF—New business model to boost orphan drug access in Europe thepharmaletter.com/in-brief… #orphandrugs #rarediseases #corporatelaunch #innovation #energy
We are providing a market-driven solution for the issue of access to orphan medicines in Europe. businesswire.com/news/home/2…
We are on a mission to redefine the #orphandrug landscape. We expand #patientaccess to medicines for #rarediseases while unlocking revenue & growth for emerging research-based #biopharmaceutical partners – through flexible, bespoke licensing & distribution partnerships across EU.
Launching Avanzanite Bioscience Today – Find out WHY: youtu.be/TgKgfuPvbjQ
#orphandrugs #rarediseases #patientaccess
#innovation #corporatelaunch